Spin-off - ASP Isotopes Inc.
Form Type: 424B5
Filing Date: 2025-06-02
Corporate Action: Spin-off
Type: Update
Accession Number: 000147793225004311
Filing Summary: ASP Isotopes Inc. filed a prospectus supplement related to the offering of 7,518,797 shares of common stock at an offering price of $6.65 per share, aiming to raise approximately $50 million. The company's stock is listed on Nasdaq under the symbol 'ASPI.' The document outlines their technology aimed at producing isotopes, particularly enriched Carbon-14, Silicon-28, and Ytterbium-176, through advanced methods such as Aerodynamic Separation and Quantum Enrichment. Additionally, ASP Isotopes is planning a spin-off of its subsidiary Quantum Leap Energy LLC, focused on advanced nuclear fuels, projected to occur in the second half of 2025, following necessary approvals. The company also discusses their plans to acquire Renergen Limited, a producer of liquefied helium and gas, through a scheme of arrangement, which will designate Renergen as a wholly-owned subsidiary. The offer’s conditions focus on necessary consents and regulatory approvals being fulfilled by September 30, 2025, to maintain the integrity of existing financial arrangements.
Additional details:
Offering Price Per Share: 6.65
Total Offering Value: 50000000
Underwriting Discounts And Commissions: 3000000
Proceeds To Company: 47000000
Stock Symbol: ASPI
Number Of Shares Offered: 7518797
Date Of Delivery To Purchasers: 2025-06-03
Anticipated Spin Off Date: Second half of 2025
Acquisition Target: Renergen Limited
Spin Off Target: Quantum Leap Energy LLC
Scheme Conditions Deadline: 2025-09-30
Form Type: S-3
Filing Date: 2025-04-30
Corporate Action: Spin-off
Type: New
Accession Number: 000147793225003146
Filing Summary: ASP Isotopes Inc. has filed a registration statement for a continuous offering of securities totaling up to $100 million, as well as an equity distribution agreement for the sale of up to $25 million in common stock. The company is focused on the development of advanced materials and isotope enrichment technologies, mainly Carbon-14, Silicon-28, and Ytterbium-176, to serve various industries including pharmaceuticals and semiconductors. ASP Isotopes is planning a spin-off of its subsidiary Quantum Leap Energy LLC (QLE) into a separate public company by the second half of 2025, subject to market conditions and necessary approvals. The company aims to maximize shareholder value and has established agreements for the supply of enriched isotopes. Their operations include multiple enrichment facilities located in Pretoria, South Africa, with plans for expansion into the U.S. and Iceland. They are also actively pursuing uranium enrichment initiatives.
Additional details:
State Of Incorporation: Delaware
Irs Employer Identification Number: 87-2618235
Address: 601 Pennsylvania Avenue NW South Building, Suite 900 Washington, D.C. 20004
Equity Distribution Agreement Amount: 25.0 million
Total Offering Amount: 100.0 million
Anticipated Start Date: 2025-04-30
Last Reported Sale Price: 5.36
Comments
No comments yet. Be the first to comment!